Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-06 | Cullinan Therapeutics, Inc. | Michaelson Jennifer
(Chief Scientific Officer) |
S | Common Stock | D | 63606 | $27.82 - $30.06 | $1,796,674 |
| 2024-05-06 | Cullinan Therapeutics, Inc. | Michaelson Jennifer
(Chief Scientific Officer) |
M | Common Stock | A | 55606 | $4.30 - $4.30 | $239,105 |
| 2024-02-01 | Cullinan Oncology, Inc. | Savill Corrine
(Chief Business Officer) |
S | Common Stock | D | 40000 | $16.18 - $16.18 | $647,200 |
| 2024-02-01 | Cullinan Oncology, Inc. | Savill Corrine
(Chief Business Officer) |
M | Common Stock | A | 40000 | $4.30 - $4.30 | $172,000 |
| 2024-01-29 | Cullinan Oncology, Inc. | Savill Corrine
(Chief Business Officer) |
S | Common Stock | D | 40000 | $14.09 - $14.09 | $563,600 |
| 2024-01-29 | Cullinan Oncology, Inc. | Savill Corrine
(Chief Business Officer) |
M | Common Stock | A | 40000 | $4.30 - $4.30 | $172,000 |
| 2023-12-18 | Cullinan Oncology, Inc. | Trigilio Jeffrey
(Chief Financial Officer) |
S | Common Stock | D | 398 | $8.22 - $8.22 | $3,271 |
| 2023-12-12 | Cullinan Oncology, Inc. | Trigilio Jeffrey
(Chief Financial Officer) |
S | Common Stock | D | 1926 | $7.81 - $7.81 | $15,042 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |